Celldex Therapeutics buy Barclays PLC
Start price
08.05.26
/
50%
€28.82
Target price
08.05.27
€40.93
Performance (%)
0.00%
Price
08.05.26
€27.98
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC is currently unchanged from the start price. This prediction currently runs until 08.05.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 0.00% |
| iShares Core DAX® | 0,22 % |
| iShares Nasdaq 100 | 6,05 % |
| iShares Nikkei 225® | 5,72 % |
| iShares S&P 500 | 2,17 % |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Barclays PLC from $45.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.16
20.04.26
20.04.26
€38.28
20.04.27
20.04.27
-1.17%
08.05.26
08.05.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€21.80
17.12.25
17.12.25
€20.43
17.12.26
17.12.26
28.26%
08.05.26
08.05.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
34.42%
08.05.26
08.05.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.20
13.10.25
13.10.25
€21.52
13.10.26
13.10.26
24.22%
08.05.26
08.05.26